HDL superphospholipidation enhances key steps in reverse cholesterol transport

Area of Science:

• Lipid metabolism
• Cardiovascular research
• Biochemistry

Background:

• HDL-phospholipids (HDL-PL), particularly phosphatidylcholine (PC), are crucial for reverse cholesterol transport (RCT) and possess anti-atherogenic properties.
• Existing HDL therapies face challenges in efficacy, cost, and safety, with some methods disrupting HDL structure and apolipoprotein A-I (apo A-I).

Purpose of the Study:

• To develop a novel method for increasing HDL-PC without compromising HDL integrity or apo A-I levels.
• To evaluate the impact of the new method on HDL particle characteristics and cholesterol efflux capacity.

Main Methods:

• A modified detergent removal technique, termed HDL SPLn (SPLn), was employed to incorporate PC into HDL particles.
• Size exclusion chromatography and native gradient gel electrophoresis were used to analyze HDL particle size and weight.
• Kinetic analysis was performed to assess the efficiency of free cholesterol (FC) efflux to SPLn-modified HDL.

Main Results:

• SPLn successfully increased HDL-PC levels more than 10-fold without any loss of apo A-I.
• SPLn treatment dose-dependently increased HDL particle weight from approximately 120 kDa to 350 kDa.
• The catalytic efficiency (Vmax/Km) of FC efflux to SPLn HDL was enhanced by over 400% compared to native HDL.

Conclusions:

• SPLn represents a novel and effective method for enhancing HDL-PC and improving a key step in RCT.
• This approach offers a potential therapeutic strategy for cardiovascular disease by improving cholesterol efflux capacity.